DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20202331

A comparative study of intramuscular sulfate versus intravenous magnesium injection among eclampsia patients in Eastern, Uttar Pradesh, India

Uzma Kauser, Anjali Chaudhari

Abstract


Background: Hypertensive in pregnancy is the second most common cause of maternal mortality in India. Among the hypertensive disorders that complicate pregnancy, pre-eclampsia and eclampsia stand out as major causes of maternal and perinatal mortality and morbidity. The majority of deaths due to pre-eclampsia and eclampsia are avoidable through the provision of timely and effective care to the women presenting with these complications. Objectives of this study were to find out the effectiveness of intravascular and intramuscular magnesium sulfate in management of eclampsia. To compare the side effects and complications of intravascular and intramuscular magnesium sulfate in management of eclampsia.

Methods: A total 100 patients presenting with eclamptic fits reporting to the center that has been included in the study. The study has been conducted in the labor room of Nehru Chikitsalaya of B. R. D. Medical College, Gorakhpur, Uttar Pradesh for 12 months duration period. Statistical analysis of observations has been done by Chi-square test with p-value <0.05 has been considered in the study.

Results: Majority of eclampsia patients belonged to 20-25 years age group (63%) followed by above 30 years of age (22%).  Nearly 16% patients in IM MgSO4 group and 12% patients in IV MgSO4 received recurrence of seizure after starting of treatment (p value >0.5). About 26% patients in IM MgSO4 group and 18% patients in IV MgSO4 group had mild side effects of MgSO4 but no patients in both the group had major side effects of MgSO4.

Conclusions: The study concludes that intramuscular injection of MgSO4 is painful and the chances of abscess formation that's why compliance of intramuscular MgSO4 is not very good in compared to intravascular infusion of MgSO4. The chances of Mg toxicity are more MgSO4 regimen because of the dose required in IM MgSO4 regimen is more (44gm) that of IV MgSO4 (28 gm).


Keywords


Eclampsia, Maternal morbidity, Maternal mortality, Pregnancy complication

Full Text:

PDF

References


Say L, Chou D, Gemmill A, Tunçalp Ö, Moller AB, Daniels J, et al. Global causes of maternal death: a WHO systematic analysis. The Lancet Global Health. 2014;2(6):e323-33.

Abou Zahr C, Wardlaw TM, Choi Y. Maternal mortality in 2000: estimates developed by WHO, UNICEF and UNFPA. World Health Organization; 2004.

Murray CJL, Lopez AD III. Health dimensions of sex and reproduction. Global Burden of Disease and Injury Series. Cambridge, MA: Harvard School of Public Health; 1998.

Ministry of Health and Family Welfare, India. Annual Report. New Delhi: Ministry of Health and Family Welfare, India. 2005:105-11.

Chesley LC, Wynn RM. Hypertensive disorders in pregnancy. New York: Appleton-Century-Crofts; 1978.

The Eclampsia Trial Collaborative Group. Which anticonvulsant for women with eclampsia? Evidence from the collaborative eclampsia trial. Lancet. 1995;345:1459-69.

Majhi AK, Chakraborty PS, Mukhopadhyay A. Eclampsia: Present scenario in a referral medical college hospital. J Obstet Gynaecol India. 2001;51:143-7.

Saha S, Ghosh Roy S, Ganguly RP, Das A. Comparative study on the efficacy of magnesium sulphate and diazepam in the management of eclampsia in a peripheral rural medical college (A cross over study of 440 cases). J Obstet Gynaecol India. 2002;52:69-72.

Datta MR, Pant L, Kabiraj M, Basu SB. Magnesium sulphate in eclampsia: A safe, efficient and cost‐effective approach. J Obstet Gynecol. 2002;52:65-8.

Pritchard JA, Cunningham FG, Pritchard SA. The Parkland Hospital protocol for treatment of eclampsia: Evaluation of 245 cases. Am J Obstet Gynecol. 1984;148:951-63.

Lucas MJ, Leveno JK, Cunningham FG. A comparison of Magnesium sulfate with Phenytoin for the prevention of eclampsia. N Engl J Med. 1995;334:201-6.

Zuspan FP. Treatment of severe preeclampsia and eclampsia. Clin Obstet Gynecol. 1966;9:954-72.

Sibai BM. Magnesium sulphate therapy in pre‐eclampsia and eclampsia. Obstet Gynaecol. 1998;92:883-9.

Singh S, Behera A. Eclampsia in Eastern India: incidence, demographic profile and response to three different anticonvulsant regimes of magnesium sulphate. Internet J Gynecol Obstet. 2010;15(2):7708.

Begum MR, Begum A, Quadir E, Akhter S, Shamsuddin L. Eclampsia still a problem in Bangladesh. Med Gen Med. 2004;6:52.

Begum MR, Begum A, Quadir E. Loading dose versus standard regime of magnesium sulfate in the management of eclampsia: a randomized controlled trial. J Obstet Gynaecol Res. 2002;28:154-9.

Hatjis CG, Swain M. Systemic tocolysis for premature labor is associated with an increased incidence of pulmonary edema in the presence of maternal infection. Am J Obstet Gynecol. 1988;159(3):723-8.

Jamila G, Naila S, Afat H. The effectiveness of complex prevention of preeclampsia using immunoglobulins. J Multidiscipli Dis. 2019;37(2):11-6.